Literature DB >> 3673507

Induction of synchronized relapses in SJL/J mice with chronic relapsing experimental allergic encephalomyelitis.

P B Kozlowski1, G B Schuller-Lewis, H M Wisniewski.   

Abstract

Chronic relapsing experimental allergic encephalomyelitis (CR-EAE) was induced in SJL/J mice by two injections of encephalitogenic emulsion. The majority of mice developed multiple relapses from day 22 to day 367 post injection. To induce synchronized relapses a third injection of the encephalitogenic emulsion was given. Almost all mice that received the third injection developed an acute, synchronized relapse with severe clinical signs within 7 to 11 days. Histologically, there was no difference between the lesions in the spontaneous versus the precipitated relapse. CR-EAE in SJL/J mice modified with the third injection offers an advantage of a reproducible and well-timed acute relapse, which allows precise dissection of the immunological events governing spontaneous relapses in chronic EAE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3673507     DOI: 10.1007/bf00692847

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse.

Authors:  U Traugott; D E McFarlin; C S Raine
Journal:  Cell Immunol       Date:  1986-05       Impact factor: 4.868

Review 2.  Pathogenetic aspects of multiple sclerosis and experimental models of inflammatory demyelination.

Authors:  H M Wisniewski; G B Schuller-Levis; P D Mehta; R E Madrid; H Lassmann
Journal:  Concepts Immunopathol       Date:  1985

3.  Cyclosporin A treatment of an induced attack in a chronic relapsing model of experimental allergic encephalomyelitis.

Authors:  G B Schuller-Levis; P B Kozlowski; H M Wisniewski
Journal:  Clin Immunol Immunopathol       Date:  1986-08

Review 4.  Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.

Authors:  C S Raine
Journal:  Lab Invest       Date:  1984-06       Impact factor: 5.662

5.  Murine experimental allergic encephalomyelitis.

Authors:  D E McFarlin
Journal:  Acta Neuropathol Suppl       Date:  1983

6.  Etiology and pathogenesis of monophasic and relapsing inflammatory demyelination - human and experimental.

Authors:  H M Wisniewski; H Lassmann
Journal:  Acta Neuropathol Suppl       Date:  1983

7.  Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.

Authors:  A Brown; D E McFarlin; C S Raine
Journal:  Lab Invest       Date:  1982-02       Impact factor: 5.662

8.  Relapsing experimental allergic encephalomyelitis in the SJL/J mouse.

Authors:  A M Brown; D E McFarlin
Journal:  Lab Invest       Date:  1981-09       Impact factor: 5.662

9.  Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker.

Authors:  M K Waldor; S Sriram; R Hardy; L A Herzenberg; L A Herzenberg; L Lanier; M Lim; L Steinman
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

  9 in total
  1 in total

1.  High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  B Oxombre; C Lee-Chang; A Duhamel; M Toussaint; M Giroux; M Donnier-Maréchal; P Carato; D Lefranc; H Zéphir; L Prin; P Melnyk; P Vermersch
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.